AI
Monday, June 20, 2011 9:00:09 AM
FIVE reasons SNDY could see .05-.10 this week..
1. The float is only 19M which was confirmed again Last week by the Transfer agent. The O/S is 69M putting the Market cap under $800K.
2. The company signed multiple purchase orders last week and has many more venues of revenue that will generate additional monies.
"We are very pleased to be supplying our MammoView system to top cancer care and research organizations in the world. We are pleased that these hospitals have not only chosen the Solos MammoView, but they have also chosen to re order the product multiple times," stated Bob Segersten, President of Solos Endoscopy, Inc
3. There has been no dilution which as been confirmed!
5. They have a multitude of FDA approved products, some of which could revolutionize the industry. Their mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.
4. SNDY to Enter the $94 Billion European Medical Device Market with their FDA approved Mammoview.
1. The float is only 19M which was confirmed again Last week by the Transfer agent. The O/S is 69M putting the Market cap under $800K.
2. The company signed multiple purchase orders last week and has many more venues of revenue that will generate additional monies.
"We are very pleased to be supplying our MammoView system to top cancer care and research organizations in the world. We are pleased that these hospitals have not only chosen the Solos MammoView, but they have also chosen to re order the product multiple times," stated Bob Segersten, President of Solos Endoscopy, Inc
3. There has been no dilution which as been confirmed!
5. They have a multitude of FDA approved products, some of which could revolutionize the industry. Their mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.
4. SNDY to Enter the $94 Billion European Medical Device Market with their FDA approved Mammoview.
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
